In vitro evaluation of antimycobacterial activity of bioresorbable implants impregnated with silver nanoparticles and antimycobacterial drugs in the treatment of pulmonary tuberculosis
Журнал: Saratov Medical Journal @sarmj
Статья в выпуске: 2 Vol.7, 2026 года.
Бесплатный доступ
Objective: To evaluate the antimycobacterial activity of bioresorbable implants based on polylactide (PLA), polycaprolactone (PCL), and chitosan, impregnated with silver nanoparticles and antituberculosis drugs (ATDs). Materials and methods. The in vitro study included two experiments, each repeated three times. We studied bioresorbable implants based on PLA/PCL and chitosan, impregnated with silver nanoparticles, silver proteinate, or one of seven ATDs (delamanid, linezolid, bedaquiline, moxifloxacin, capreomycin, isoniazid, amikacin). Antimycobacterial activity was assessed by agar diffusion, in the BD BACTEC™ MGIT™ Mycobacterial System, and by broth microdilution using the Mycobacterium tuberculosis H37Rv reference strain. Results. High concentrations of silver nanoparticles (0.034-0.042 nmol/mL) demonstrated bactericidal activity lasting for 35 days. Silver proteinate exerted a slight inhibitory effect on the growth of M. tuberculosis, delaying its growth for only 5 days vs. the control. ATDs, with the exception of delamanid, were released within the first 1-3 days and exhibited bactericidal activity against M. tuberculosis, after which their antimycobacterial activity decreased. Conclusions. Implants impregnated with silver nanoparticles provided a prolonged bactericidal effect against M. tuberculosis, which justifies further study of these implants.
Короткий адрес: https://sciup.org/149152387
IDS: 149152387 | DOI: 10.15275/sarmj.2026.0204